Cannabis Bioscience International Holdings (CBIH) has a profit margin of -416.81%, below the sector sector average of 13.16%.
Get informed when a big investor buys or sells
+ FollowAs of Feb 2026
Trailing 12 months ending Feb 2026
As of the most recent data (February 2026), CBIH shows a profit margin of -416.81%. That compares with -137.53% in the prior-year period — down 203.1% year over year. That is below the sector sector average of 13.16%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CBIH's profit margin is now -416.81% (was -137.53%) — a 203.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cannabis Bioscience International Holdings is outperforming or lagging.
The its sector sector average profit margin is about 13.16%. Cannabis Bioscience International Holdings is at -416.81%, which is lower that average. That is roughly 3266.4% below the sector mean. Use the comparison chart on this page to see how CBIH stacks up against individual peers as well.
That compares with -137.53% in the prior-year period — down 203.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Cannabis Bioscience International Holdings with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Cannabis Bioscience International Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -416.81%) with ownership activity and broader fundamentals.